# Title

 Food and Drugs. PART 200â€”GENERAL


# ID

 CFR-2018-title21-vol4.Pt. 200


# Structured Analysis Summary

| Type        | Values                           |
|:------------|:---------------------------------|
| Constraints | ['within', 'more than']          |
| Condition   | ['when', 'if', 'until', 'where'] |
| Entities    | ['Food', 'Such', 'Ophthalmic']   |
| Date        | ['2018-03-08', '1964-09-01']     |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                         |
|:--------------|:----------------------------------------------------------------------------------------------------------------|
| more than     | if the octadecylamine in the steam is not more than  2.4 parts per million.                                     |
| within        | are not sterile may be regarded as adulterated within the meaning of section 501(c) of the Federal              |
| within        | are not sterile may be regarded as adulterated within the meaning of section 501(c) of the Federal              |
| within        | package is opened and be labeled, on or within the retail package, so as to afford adequate                     |
| more than     | single active ingredient or if the product contains more than one active ingredient and a relevant strength can |


## Condition

| Condition   | Context                                                                                                           |
|:------------|:------------------------------------------------------------------------------------------------------------------|
| when        | concerns a significant hazard to health, the statement: when                                                      |
| when        | important changes in drug package labeling, the statement: when                                                   |
| when        | of prescription drug advertising or labeling, the statement: when                                                 |
| where       | to the use of octadecylamine in steam lines where the steam may be used for autoclaving surgical                  |
| if          | be used for autoclaving surgical instruments and gauze if the octadecylamine in the steam is not more             |
| if          | and Drug Administration concludes that all such preparations, if they are not sterile, fall below their professed |
| if          | below their professed standard of purity or quality if  they are not sterile.                                     |
| if          | These articles, which are regulated as drugs  if packaged with the drugs with which they are                      |
| until       | should be packaged so as to maintain sterility until the package is opened and be labeled, on                     |
| if          | of &#167;&#167;&#8201;201 .100 and 202.1 of this chapter if all of the following conditions are met: (1)          |
| if          | contains the proprietary name of the drug product, if any; the established (generic) name of the drug             |
| if          | contains the proprietary name of the drug product, if any; the established (generic) name of the drug             |
| if          | contains the proprietary name of the drug product, if any; the established (generic) name of the drug             |
| if          | contains the proprietary name of the drug product, if any; the established (generic) name of the drug             |
| if          | the drug product, professional fees, and handling fees, if  any.                                                  |
| if          | Mailing fees and delivery fees,  if  any, may be stated separately and without repetition.                        |


## Entities

| Entities   | Context                                             |
|:-----------|:----------------------------------------------------|
| Food       | Food  and Drugs.                                    |
| Ophthalmic | Ophthalmic  preparations and dispensers.            |
| Such       | Such action may be taken against the product and/or |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                              |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2018-03-08 | (c) The following statements are to appear in the far left third of the envelope front, in the type and size indicated, centered in a rectangular space approximately 3 inches wide and 21/4 inches high with an approximately 3/8 inch-wide border in the color indicated:                                                                                                                          |
| 1964-09-01 | In a statement of policy issued on September 1, 1964, the Food and Drug Administration ruled that liquid preparations offered or intended for ophthalmic use that are not sterile may be regarded as adulterated within the meaning of section 501(c) of the Federal Food, Drug, and Cosmetic Act (the act), and, further, may be deemed misbranded within the meaning of section 502(j) of the act. |


